EPI-X4-JM-21

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameEPI-X4-JM-21

Drug Alias NameEPI-X4-JM#21EPI-X4-JM-21

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists

TargetsC-X-C motif chemokine receptor 4

Therapy Area/IndicationsDermatitis, AtopicAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUlm University

China Registration ClassN/A

Active CompaniesUlm University

Inactive CompaniesN/A

Active IndicationsDermatitis, AtopicAsthma

Inactive IndicationsN/A

ATC CodeN/A